Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06279221

Litfulo Capsules Special Investigation

Litfulo® Capsules Special Investigation

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
487 (actual)
Sponsor
Pfizer · Industry
Sex
All
Age
0 Years
Healthy volunteers
Not accepted

Summary

The objective of this Study is to confirm the safety during the long-term use of this drug and the effectiveness during the use of this drug under the actual use in the patients treated with this drug.

Detailed description

This study is an open-label, multi-center, one arm prospective observational cohort study of patients receiving this drug. The investigators complete the CRF based on the information extracted from the medical record created in daily medical practice.

Conditions

Interventions

TypeNameDescription
DRUGLITFULOas provided in real world practice

Timeline

Start date
2024-03-01
Primary completion
2030-04-24
Completion
2030-04-24
First posted
2024-02-28
Last updated
2026-03-02

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT06279221. Inclusion in this directory is not an endorsement.

Litfulo Capsules Special Investigation (NCT06279221) · Clinical Trials Directory